RAS突变在EML4-ALK阳性肺癌联合治疗中的作用
评价者:黄诚1, 林根1, 文献合成者:黎扬斯2

RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer
Reviewers:HUANG Cheng1, LIN Gen1, Literature Co-worker: LI Yang-si2